Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vincent Medical Holdings Limited ( (HK:1612) ) has issued an announcement.
Vincent Medical Holdings Limited has announced amendments to the terms of reference for its Remuneration Committee, effective from August 20, 2025. The changes emphasize the committee’s role in determining remuneration policies for directors and senior management, ensuring a majority of independent non-executive directors, and maintaining a minimum of three members. This move is likely aimed at enhancing governance and aligning the company’s remuneration practices with industry standards, potentially impacting stakeholder confidence positively.
The most recent analyst rating on (HK:1612) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Vincent Medical Holdings Limited stock, see the HK:1612 Stock Forecast page.
More about Vincent Medical Holdings Limited
Vincent Medical Holdings Limited is a company incorporated in the Cayman Islands, operating with its subsidiaries as a group. The company is listed under stock code 1612 and focuses on providing medical products and services.
Average Trading Volume: 1,741,000
Technical Sentiment Signal: Buy
Current Market Cap: HK$594.5M
See more data about 1612 stock on TipRanks’ Stock Analysis page.